October 2025 FDA Recall Fesoterodine Fumarate by Alembic Pharmaceuticals Limited
D-0156-2026 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Alembic Pharmaceuticals Limited on October 10, 2025 for the product Fesoterodine Fumarate. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0156-2026

Reason for Recall
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Initiated
10-10-2025
Reported
11-26-2025
Quantity
4,884 30-count bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Alembic Pharmaceuticals Limited
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide in the USA.
Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30

Batch or Lot Expiration Information

Lot# 2405006633, Exp Date: 03/31/2026